The Healthcare Products Regulatory Authority (HPRA) has published its 2025 Annual Report, outlining a year of significant achievement across its regulatory remit and marking the successful conclusion of…
Stakeholders at the AXIS Patient Access Conference in Dublin heard that Ireland must agree a clear operational roadmap to meet its 180-day reimbursement decision target.
The Minister for Health has announced a set of Government-approved recommendations designed to expand clinical trials in Ireland, enhance patient access and strengthen national research infrastructure. Plans include a Clinical Trials Advisory Council in early 2026 and a National Clinical Trials Body by Autumn 2027.
Meril Life Sciences has shared one-year outcomes from the pivotal LANDMARK RCT at PCR London Valves 2025, confirming comparable efficacy and superior extended clinical outcomes for the Myval THV series alongside the lowest regurgitation rates among leading transcatheter valves.
